PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
HRTX vs. NVDA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between HRTX and NVDA is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

HRTX vs. NVDA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Heron Therapeutics, Inc. (HRTX) and NVIDIA Corporation (NVDA). The values are adjusted to include any dividend payments, if applicable.

0.00%100,000.00%200,000.00%300,000.00%400,000.00%JulyAugustSeptemberOctoberNovemberDecember
-99.62%
358,144.68%
HRTX
NVDA

Key characteristics

Sharpe Ratio

HRTX:

-0.03

NVDA:

3.44

Sortino Ratio

HRTX:

0.69

NVDA:

3.64

Omega Ratio

HRTX:

1.09

NVDA:

1.46

Calmar Ratio

HRTX:

-0.02

NVDA:

6.66

Martin Ratio

HRTX:

-0.07

NVDA:

20.59

Ulcer Index

HRTX:

35.48%

NVDA:

8.74%

Daily Std Dev

HRTX:

96.35%

NVDA:

52.29%

Max Drawdown

HRTX:

-99.96%

NVDA:

-89.73%

Current Drawdown

HRTX:

-99.88%

NVDA:

-9.52%

Fundamentals

Market Cap

HRTX:

$250.96M

NVDA:

$3.19T

EPS

HRTX:

-$0.16

NVDA:

$2.53

PEG Ratio

HRTX:

-0.18

NVDA:

0.81

Total Revenue (TTM)

HRTX:

$147.20M

NVDA:

$113.27B

Gross Profit (TTM)

HRTX:

$99.43M

NVDA:

$85.93B

EBITDA (TTM)

HRTX:

-$22.21M

NVDA:

$74.87B

Returns By Period

In the year-to-date period, HRTX achieves a -7.06% return, which is significantly lower than NVDA's 172.06% return. Over the past 10 years, HRTX has underperformed NVDA with an annualized return of -16.65%, while NVDA has yielded a comparatively higher 75.35% annualized return.


HRTX

YTD

-7.06%

1M

41.07%

6M

-51.08%

1Y

-9.20%

5Y*

-42.26%

10Y*

-16.65%

NVDA

YTD

172.06%

1M

-7.66%

6M

6.44%

1Y

175.01%

5Y*

86.75%

10Y*

75.35%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

HRTX vs. NVDA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Heron Therapeutics, Inc. (HRTX) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for HRTX, currently valued at -0.03, compared to the broader market-4.00-2.000.002.00-0.033.44
The chart of Sortino ratio for HRTX, currently valued at 0.69, compared to the broader market-4.00-2.000.002.004.000.693.64
The chart of Omega ratio for HRTX, currently valued at 1.09, compared to the broader market0.501.001.502.001.091.46
The chart of Calmar ratio for HRTX, currently valued at -0.02, compared to the broader market0.002.004.006.00-0.026.66
The chart of Martin ratio for HRTX, currently valued at -0.07, compared to the broader market-5.000.005.0010.0015.0020.0025.00-0.0720.59
HRTX
NVDA

The current HRTX Sharpe Ratio is -0.03, which is lower than the NVDA Sharpe Ratio of 3.44. The chart below compares the historical Sharpe Ratios of HRTX and NVDA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.00JulyAugustSeptemberOctoberNovemberDecember
-0.03
3.44
HRTX
NVDA

Dividends

HRTX vs. NVDA - Dividend Comparison

HRTX has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.02%.


TTM20232022202120202019201820172016201520142013
HRTX
Heron Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NVDA
NVIDIA Corporation
0.02%0.03%0.11%0.05%0.12%0.27%0.46%0.29%0.45%1.20%1.70%1.94%

Drawdowns

HRTX vs. NVDA - Drawdown Comparison

The maximum HRTX drawdown since its inception was -99.96%, which is greater than NVDA's maximum drawdown of -89.73%. Use the drawdown chart below to compare losses from any high point for HRTX and NVDA. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-99.73%
-9.52%
HRTX
NVDA

Volatility

HRTX vs. NVDA - Volatility Comparison

Heron Therapeutics, Inc. (HRTX) has a higher volatility of 38.30% compared to NVIDIA Corporation (NVDA) at 10.07%. This indicates that HRTX's price experiences larger fluctuations and is considered to be riskier than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%JulyAugustSeptemberOctoberNovemberDecember
38.30%
10.07%
HRTX
NVDA

Financials

HRTX vs. NVDA - Financials Comparison

This section allows you to compare key financial metrics between Heron Therapeutics, Inc. and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab